참고문헌
- Adams, J. M. and S. Cory. 2002. Apoptosomes: engines for caspase activation. Curro Opin. Cell BioI. 14, 715-720 https://doi.org/10.1016/S0955-0674(02)00381-2
- Belmokhtar, C. A, J. Hillion, C. Dudognon, S. Fiorentino, M. Flexor, M. Lanotte, and E. Segal-Bendirdjian. 2003. Apoptosome-independent pathway for apoptosis.Biochemical analysis of AP AF-l defects and biological outcomes. J. BioI. Chem. 278, 29571-29580 https://doi.org/10.1074/jbc.M302924200
- Bidon, N., F. Brichory, D. Thomas, A Cavalier, S. Caulet-Maugendre, P. Bourguet, and L. Dazord. 2001. Sodium butyrate induces growth inhibition and modulates galectin-8 expression in human lung carcinoma cells. Anticancer Res. 21, 1049-1055
- Chopin, V., R A Toillo, N. Jouy, and X. Le Bourhis. 2002. Sodium butyrate induces P53-independent, Fas-mediated apoptosis in MCF-7 human breast cancer cells. Br. J. Pharmacal. 135, 79-86 https://doi.org/10.1038/sj.bjp.0704456
- Cobb, M. H. 1999. MAP kinase pathways. Prog. Biophys. Mol. BioI. 71, 479-500 https://doi.org/10.1016/S0079-6107(98)00056-X
- Cross, T. G, D, Scheel-Toellner, N. V. Henriquez, E. Deacon, M. Salmon, and J. M. Lord. 2000. Serine/threonine protein kinases and apoptosis. Exp. Cell Res. 256, 34-41 https://doi.org/10.1006/excr.2000.4836
- DanieL J. C., and W. R 2003. Smythe. Gene therapy of lung cancer. Semin. Surg. Oneol. 21, 196-204 https://doi.org/10.1002/ssu.10038
- Davis, R J. 2000. Signal transduction by the JNK group of MAP kinases. Cell 103, 239-252 https://doi.org/10.1016/S0092-8674(00)00116-1
- Edwards, A, J. Li, P. Atadja, K. Bhalla, and E. B. Haura. 2007. Effect of the histone deacetylase inhibitor LBH589 against epidermal growth factor receptor-dependent human lung cancer cells. Mol. Cancer Ther. 6, 2515-2524 https://doi.org/10.1158/1535-7163.MCT-06-0761
- Greenberg, V. L., J. M. Williams, J. P. Cogswell, M. Mendenhall, and S. G Zimmer. 2001. Histone deacetylase inhibitors promote apoptosis and differential cell cycle arrest in anaplastic thyroid cancer cells. Thyroid 11, 315-325 https://doi.org/10.1089/10507250152039046
- Hansen, T. M. and P. Nagley. 2003. AIF: a multifunctional cog in the life and death machine. Sci. STKE. 29, PE31
- Hernandez, A, R Thomas, F. Smith, J. Sandberg, S. Kim, D. H. Chung, and B. M. Evers. 2001. Butyrate sensitizes human colon cancer cells to TRAIL-mediated apoptosis. Surgery 130, 265-272 https://doi.org/10.1067/msy.2001.115897
- Komatsu, N., N. Kawamata, S. Takeuchi, D. Yin, W. Chien, C. W. Miller, and H. P. Koeffler. 2006. SAHA, a HDAC inhibitor, has profound anti-growth activity against non-small cell lung cancer cells. Oneol. Rep. 15, 187-191
- Kosmidis, P. A and C. Manegold. 2003. Advanced NSCLC: New cytostatic agents. Lung Cancer 41 (Suppl), S123-132
- Lansiaux, A, M. Facompre, N. Wattez, M. P. Hildebrand, C. BaL D. Demarquay, O. Lavergne, D. C. Bigg, and C. Bailly. 2001. Apoptosis induced by the homocamptothecin anticancer drug BN80915 in HL-60 cells. Mol. Pharmacol. 60, 450-461
- Lee, E. M., S. Shin, H. J. Cha, Y. Yoon, S. Bae, J. H. Jung, S. M. Lee, S. J. Lee, I. C. Park, Y. W. Jin, and S. An. 2009. Suberoylanilide hydroxamic acid (SAHA) changes microRNA expression profiles in A549 human non-small cell lung cancer cells. Int. J. Mol. Med. 24, 45-50
- Mai, A, S. Massa, D. Rotili, I. Cerbara, S. Valente, R Pezzi, S. Simeon, and R Ragno. 2005. Histone deacetylation in epigenetics: an attractive target for anticancer therapy. Med. Res. Rev. 25, 261-309 https://doi.org/10.1002/med.20024
- Manegold, C. 2001. Chemotherapy for advanced non-small cell lung cancer: standards. Lung Cancer 34 (Suppl), S165-170 https://doi.org/10.1016/S0169-5002(01)00363-4
- Marks, P. A, T. M. Richon, T. Miller, and W. K. Kelly. 2004. Histone deacetylase inhibitors. Adv. Cancer Res. 91, 137-168 https://doi.org/10.1016/S0065-230X(04)91004-4
- Marks, P. A, T. Miller, and V. M. Richon. 2004. Histone deacetylases. Curro Opin. Pharmacol. 3, 344-351 https://doi.org/10.1016/S1471-4892(03)00084-5
- Marks, P. A, V. M. Richon, and R A Rifkind. 2000. Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J. Natl. Cancer Inst. 92,1210-1216 https://doi.org/10.1093/jnci/92.15.1210
- Muhlethaler-Mottet, A, R Meier, M. Flahaut, K. B. Bourloud, K. Nardou, J. M. Joseph, and N. Gross. 2008. Complex molecular mechanisms cooperate to mediate histone de acetylase inhibitors anti-tumour activity in neuroblastoma cells. Mol. Cancer 7, 55 https://doi.org/10.1186/1476-4598-7-55
- Pearson, G, F. Robinson, T. Beers Gibson, B. E. Xu, M. Karandikar, K. Berman, and M. H. Cobb. 2001. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocrinol. Rev. 22, 153-183 https://doi.org/10.1210/er.22.2.153
- Rahmani, M., E. Reese, Y. Dai, C. Bauer, S. G Payne, P. Dent, S. SpiegeL and S. Grant. 2005. Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERKl/2 inactivation and the generation of ceramide and reactive oxygen species. Cancer Res. 65, 2422-2432 https://doi.org/10.1158/0008-5472.CAN-04-2440
- Reddy, K. B., S. M. Nabha, and N. Atanaskova. 2003. Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev. 22, 395-403 https://doi.org/10.1023/A:1023781114568
- Rosato, R R, S. C. Maggio, J. A Almenara, S. G Payne, P. Atadja, S. SpiegeL P. Dent, and S. Grant. 2006. The histone deacetylase inhibitor LAQ824 induces human leukemia cell death through a process involving XIAP down-regulation, oxidative injury, and the acid sphingomyelinase-dependent generation of ceramide. Mol. Pharmacol. 69, 216-225
- Sahara, S., M. Aoto, Y. Eguchi, N. Imamoto, Y. Yoneda, and Y. Tsujimoto. 1999. Acinus is a caspase-3-activated protein required for apoptotic chromatin condensation. Nature 401, 168-173 https://doi.org/10.1038/43678
- Sharma, K R X. Wang, L. Y. Zhang, D. L. Yin, X. Y. Luo, J. C. Solomon, R F. Jiang, K. Markos, W. Davidson, D. W. Scott, and Y. F. Shi. 2000. Death the Fas way: regulation and pathophysiology of CD95 and its ligand. Pharmacal. Ther. 88, 333-347 https://doi.org/10.1016/S0163-7258(00)00096-6
- Shivapurkar, N., J. Reddy, P. M. Chaudhary, and A F. Gazdar. 2003. Apoptosis and lung cancer. J. Cell Biochem. 88, 885-898 https://doi.org/10.1002/jcb.10440
- Terao, Y., J. Nishida, S. Horiuchi, F. Rong, Y. Ueoka, T. Matsuda, H. Kato, Y. Furugen, K. Yoshida, K. Kato, and N. Wake. Sodium butyrate induces growth arrest and senescence-like phenotypes in gynecologic cancer cells. Int. J. Cancer 94, 257-267 https://doi.org/10.1002/ijc.1448
- Wada, T. and J. M. Penninger. 2004. Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23, 2838-2849 https://doi.org/10.1038/sj.onc.1207556
- Widlak, P. 2000. The DFF40/ CAD endonuclease and its role in apoptosis. Acta Biochim. Pol. 47, 1037-1044
- Xia, Z., M. Dickens, J. Raingeaud, R. J. Davis, and M. E. Greenberg. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270, 1326-1331 https://doi.org/10.1126/science.270.5240.1326
- Yoon, H. S., S. C Moon, N. D. Kim, B. S. Park M. H. Jeong, and Y. H. Yoo. 2000. Genistein induces apoptosis of RPE-J cells by opening mitochondrial PTP. Biochem. Biophys. Res. Commun. 276, 151-156 https://doi.org/10.1006/bbrc.2000.3445
- Zangemeister-Wittke, U. and R. A. Stahel. 1999. Novel approaches to the treatment of small-celliung cancer. Cell Mol. Life Sci. 55, 1585-1598 https://doi.org/10.1007/s000180050398
- Zhang, J. H. and M. Xu. 2000. DNA fragmentation in apoptosis. Cell Res. 10, 5-11 https://doi.org/10.1038/sj.cr.7290049
- Zhang, X. D., S. K. Gillespie, J. M. Borrow, and P. Hersey. 2004. The histone deacetylase inhibitor suberic bishydroxamate regulates the expression of multiple apoptotic mediators and induces mitochondria-dependent apoptosis of melanoma cells. Mol. Cancer Ther. 3, 425-435
- Zimmermann, K. C, C Bonzon, and D. R. Green. 2001. The machinery of programmed cell death. Pharmacol. Ther. 92, 57-70 https://doi.org/10.1016/S0163-7258(01)00159-0
피인용 문헌
- Effects of Butyrate on Colorectal Cancer vol.23, pp.1, 2013, https://doi.org/10.5352/JLS.2013.23.1.143